Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
University of Miami
Institute of Hematology & Blood Diseases Hospital, China
Wake Forest University Health Sciences
Mayo Clinic
University of Iowa
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
University of Rochester
Mayo Clinic
Affiliated Hospital of Qinghai University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
University of Nebraska
Northwestern University
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
JaxBio Ltd
Cancer Support Community, Research and Training Institute, Philadelphia
Melbourne Health
University Hospital, Clermont-Ferrand
University of Liege